Home
>
US Stocks
>
Anixa Biosciences Inc
Anixa Biosciences Inc
ANIX

Anixa Biosciences Inc (ANIX)

$4.3710.82%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$4.37
Today Low/High
$4.37 / $4.37
52 Week Low/High
$1.7 / $8.09
Market Cap
$121M

Company Details

Anixa Biosciences Inc. is a biotechnology company developing a number of programs addressing cancer and infectious disease. Anixa's therapeutics portfolio includes a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a Covid-19 therapeutics program focused on inhibiting certain viral protein function. The company's vaccine portfolio includes a vaccine to prevent breast cancer, and specifically triple negative breast cancer (TNBC), the most deadly form of the disease, and a vaccine to prevent ovarian cancer. These vaccine technologies focus on immunizing against specific proteins that have been found to be expressed in certain forms of cancer. Anixa continually examines emerging technologies in complementary fields for further development and commercialization.
Organisation
Anixa Biosciences Inc
Headquaters
San Jose, California, US
Employees
4
Industry
Electronic Technology
CEO
Amit Kumar

Discover more

Frequently Asked Questions

What is Anixa Biosciences Inc (ANIX) share price today?

Can Indians buy Anixa Biosciences Inc (ANIX) shares?

How can I buy Anixa Biosciences Inc (ANIX) shares from India?

Can Fractional shares of Anixa Biosciences Inc (ANIX) be purchased?

What are the documents required to start investing in Anixa Biosciences Inc (ANIX) stocks?

We are a SEBI registered investement advisor